Stereotactic Magnetic Resonance Guided Radiation Therapy

Clinical trial NCT04115254 · RECRUITING

Trial details

NCT number: NCT04115254
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Pancreas Cancer Lung Cancer Renal Cancer Adrenal Metastases Prostate Cancer Liver Metastases Oligoprogressive Nodal Metastases Metachronous Nodal Metastases Synchronous Nodal Metastases Mesothelioma Spine Metastases Brain Metastases

Start date: 2019-10-22
Primary completion: 2028-06-01
Enrollment: 397

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.